Germany· DE-A57-4c19f384f300b499

Eslicarbazepin Al

A eslicarbazepine product containing eslicarbazepine acetate, registered in Germany by Aliud Pharma Gmbh. The same ATC class is registered in 16 of our 19 countries.

ATC N03AF04

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about eslicarbazepine acetateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Eslicarbazepine is registered in 16 of 19 countries.

Countries holding a registration under ATC N03AF04 (eslicarbazepine), each read from that country’s own register.

This record: Germany, from EMA Article 57 (European Union)
10 of them publish a price we can compare per daily dose

Search eslicarbazepine products by name

Eslicarbazepine · ATC N03AF04

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eslicarbazepine costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $2.32 in Italy to $4.08 in Switzerland — a ×1.8 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Eslicarbazepine · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

CH Switzerland$4.08
ES Spain$3.49
IT Italy$2.32

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)

Active substance: Eslicarbazepine Acetate
Manufacturer: Aliud Pharma Gmbh
Country: Germany (DE)
ATC code: N03AF04
ATC class: Eslicarbazepine
Defined daily dose: 0.8 g, O
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

188 interactions on record for eslicarbazepine.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check eslicarbazepine against other medicines How interaction checks work

Eslicarbazepine · interactions on record

188 records

17 severe
166 moderate
5 minor

Most severe, free to view

Levonorgestrel and ethinylestradiolG03AA07severe
Desogestrel and ethinylestradiolG03AA09severe
Drospirenone and ethinylestradiolG03AA12severe
EthinylestradiolG03CA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eslicarbazepine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eslicarbazepine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

Austria · Eslibon
Bulgaria · Еслибон
Cyprus · Esran
Czechia · Eslibon, Eslikarbazepin Neuraxpharm
Denmark · Arupsan, Eslicarbazepinacetat "stada"
Spain · Arupsan, Bixcar
France · Eslicarbazepine 800, Eslicarbazepine Arrow
United Kingdom (Northern Ireland) · Arupsan, Eslicarbazepine Amarox
Greece · Esran
Hungary · Eslicarbazepine 800
Iceland · Eslicarbazepin, Eslicarbazepine Acetate Stada
Italy · Arupsan, Eslicarbazepina Acetato Aurobindo
Liechtenstein · Zebinix
Malta · Esran
Netherlands · Eslibon
Norway · Zebinix
Poland · Eslibon
Portugal · Acetato De Eslicarbazepina Alter, Acetato De Eslicarbazepina Aristo
Sweden · Arupsan
Slovakia · Eslibon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cd6a548f-67df-46f6-8d5a-1cbfef52713c
GET /v1/drugs/cd6a548f-67df-46f6-8d5a-1cbfef52713c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Eslicarbazepine Acetate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about eslicarbazepine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console